139 related articles for article (PubMed ID: 34999374)
21. Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats.
Zhou H; Fujigaki Y; Kato A; Miyaji T; Yasuda H; Tsuji T; Yamamoto T; Yonemura K; Hishida A
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F225-35. PubMed ID: 16467127
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of cisplatin-induced nephrotoxicity in rats by allopurinol.
Erdinç M; Erdinç L; Nergiz Y; Işik B
Exp Toxicol Pathol; 2000 Aug; 52(4):329-34. PubMed ID: 10987186
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats.
Uzunoglu S; Karagol H; Ozpuyan F; Cosar R; Cicin I; Yurutcaloglu V; Denizli B; Tanriverdi Ö; Sut N; Kocak Z
Med Oncol; 2011 Dec; 28 Suppl 1():S690-6. PubMed ID: 21140244
[TBL] [Abstract][Full Text] [Related]
24. Protective Effects of Low Dose Vorinostat on Cisplatin-Induced Nephrotoxicity in Rats.
Bashraf OMO; Ali AS; Eweis HSA; Ali SS
Curr Mol Pharmacol; 2021 Oct; 14(4):635-645. PubMed ID: 33297925
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of dendropanoxide isolated from Dendropanax morbifera against cisplatin-induced acute kidney injury via the AMPK/mTOR signaling pathway.
Park YJ; Kim KS; Park JH; Lee SH; Kim HR; Lee SH; Choi HB; Cao S; Kumar V; Kwak JH; Kim HS
Food Chem Toxicol; 2020 Nov; 145():111605. PubMed ID: 32750447
[TBL] [Abstract][Full Text] [Related]
26. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
[TBL] [Abstract][Full Text] [Related]
27. Porous Se@SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1.
Li X; Wang Q; Deng G; Liu Y; Wei B; Liu X; Bao W; Wang Q; Wu S
Toxicol Appl Pharmacol; 2019 Oct; 380():114704. PubMed ID: 31400413
[TBL] [Abstract][Full Text] [Related]
28. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane protects against cisplatin-induced nephrotoxicity.
Guerrero-Beltrán CE; Calderón-Oliver M; Tapia E; Medina-Campos ON; Sánchez-González DJ; Martínez-Martínez CM; Ortiz-Vega KM; Franco M; Pedraza-Chaverri J
Toxicol Lett; 2010 Feb; 192(3):278-85. PubMed ID: 19913604
[TBL] [Abstract][Full Text] [Related]
30. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
Watanabe H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
[TBL] [Abstract][Full Text] [Related]
31. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo.
Nagai N; Ogata H
Cancer Chemother Pharmacol; 1997; 40(1):11-8. PubMed ID: 9137523
[TBL] [Abstract][Full Text] [Related]
32. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
Saad SY; Arafah MM; Najjar TA
Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity.
Volarevic V; Djokovic B; Jankovic MG; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N
J Biomed Sci; 2019 Mar; 26(1):25. PubMed ID: 30866950
[TBL] [Abstract][Full Text] [Related]
34. Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain "gatekeeper" function.
Takeda F; Oda M; Terasaki M; Ichimura Y; Kojima H; Saitoh H
Toxicol Appl Pharmacol; 2021 Jul; 423():115570. PubMed ID: 33965372
[TBL] [Abstract][Full Text] [Related]
35. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury.
Saleh S; Ain-Shoka AA; El-Demerdash E; Khalef MM
Chemotherapy; 2009; 55(6):399-406. PubMed ID: 19955745
[TBL] [Abstract][Full Text] [Related]
37. Taurine Administration Mitigates Cisplatin Induced Acute Nephrotoxicity by Decreasing DNA Damage and Inflammation: An Immunocytochemical Study.
Tsunekawa M; Wang S; Kato T; Yamashita T; Ma N
Adv Exp Med Biol; 2017; 975 Pt 2():703-716. PubMed ID: 28849493
[TBL] [Abstract][Full Text] [Related]
38. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive Drug Combinations Modify Cisplatin-induced Acute Kidney Injury.
Takeuchi K; Sogawa R; Tsuruhashi S; Motooka C; Kimura S; Shimanoe C
In Vivo; 2022; 36(3):1391-1396. PubMed ID: 35478142
[TBL] [Abstract][Full Text] [Related]
40. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
